| 12/9/09 |
Celgene to Buy Gloucester Pharmaceuticals |
|
|
| 10/21/09 |
Deloitte Ranks ReachLocal North America's Fastest Growing Technology Company |
| 9/08/09 |
Everyday Health Names Aaron Tobin Senior Director of Strategy |
| 8/13/09 |
Waterfront Media Recognized in Inc. 5000's Fastest Growing Privately-Held Companies in America |
| 7/22/09 |
Everyday Health Adds Prestigious MayoClinic.com to its Portfolio of Sites |
| 5/06/09 |
FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia |
| 5/04/09 |
ON24 Receives 2009 Frost and Sullivan Global Market Leadership Award for Virtual Events |
| 5/01/09 |
MiddleBrook Pharmaceuticals Launches MOXATAG(TM) Website, Announces Early Prescription Data for MOXATAG |
| 4/24/09 |
NitroMed Announces Closing of Acquisition and Determination of Final Merger Consideration |
| 4/20/09 |
ReachLocal Launches ‘The ReachLocal Xchange,’ The First-Of-Its-Kind Local Advertising Platform |
| 4/19/09 |
Mersana’s Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics and Anti-Tumor Activity in Studies Presented at American Association of Cancer Research Meeting |
| 3/10/09 |
Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe |
| 3/05/09 |
MiddleBrook Pharmaceuticals Reports 2008 Fourth Quarter and Full-Year Financial and Operational Results |
| 3/03/09 |
IntraLinks Sees 180 Percent Increase in Bankruptcy and Restructuring Deals |
| 2/23/09 |
ON24 Announces Record Annual Business Performance |
| 2/17/09 |
Everyday Health Announces Most Successful Quarter to Date [Waterfront Media] |
| 2/19/09 |
Anacor Announces Positive Results from Phase 2 Psoriasis Trial |
| 2/04/09 |
Slacker Announces Availability of Mobile Radio Application for the BlackBerry Storm Smartphone |
| 1/14/09 |
Slacker Launches Personal Radio Mobile Application for iPhone |
| 1/12/09 |
Anacor Achieves Milestone from GSK for Boron-Based Systemic Antibacterial Product Candidate |
| 1/06/09 |
Anacor Raises $50 Million in Equity Financing - Investments from GlaxoSmithKline, Schering Corporation and Existing Investors |
| |
|
| |
|
